Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study
International Journal of Molecular Sciences · 17.12.2025 · 26 (24) · 12122
DOI: 10.3390/ijms262412122 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.12.2025. Verfasst von Michał Markiewicz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Quality of Life, Glial Cell Line-Derived Neurotrophic Factor, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Progressive supranuclear palsy (PSP) is a condition classified as atypical parkinsonism. Pathologically, it is a four-repeat tauopathy; clinically, it is a disease comprising oculomotor dysfunction, postural instability, akinesia, and cognitive/language disorders. Its pathogenesis is not fully recognized; however, neuroinflammation is considered to likely be a significant aspect, though it is not known whether inflammation is a cause or consequence of neurodegeneration. In this study, the authors analyzed the association between inflammatory/neurotrophic factors and parameters linked to quality of life, based on examinations of 10 controls and 11 patients with PSP. They found a negative correlation between mPSPRS (Modified Progressive Supranuclear Palsy Rating Scale) and the glial cell-line-derived neurotrophic factor levels (GDNF) (r = −0.772727, p = 0.003) in the serum, a less pronounced negative correlation between progressive supranuclear palsy–quality of life parameter (PSP-QoL) and GDNF (r = −0.68390, p = 0.011) in the serum, and no correlations were observed in the analyses of inflammatory factors. The obtained results show the association between lower levels of GDNF and more pronounced clinical deterioration. Further analysis in the field based on larger groups of patients is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
- Diagnostic Ultrasound Lab, Department of Pediatric Radiology, Medical University of Warsaw, 03-242 Warsaw, Poland.
- Department of Biochemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
- Department of Hepatology and Infectious and Tropical Diseases, Medical University of Warsaw, Provincial Infectious Diseases Hospital in Warsaw, Wolska 37, 01-201 Warsaw, Poland.
ORCID-Profile: Natalia Madetko-Alster, Marta Struga, Piotr Alster
Zitieren
APA
Markiewicz, M., Migda, B., Otto-Ślusarczyk, D., Madetko-Alster, N., Wiercińska-Drapało, A., Darewicz, M., Struga, M., & Alster, P. (2025). Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study. International Journal of Molecular Sciences, 26(24), 12122. https://doi.org/10.3390/ijms262412122
Vancouver
Markiewicz M, Migda B, Otto-Ślusarczyk D, Madetko-Alster N, Wiercińska-Drapało A, Darewicz M, et al. Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study. International Journal of Molecular Sciences. 2025;26(24):12122. doi:10.3390/ijms262412122
BibTeX
@article{Markiewicz2025,
author = {Markiewicz, Michał and Migda, Bartosz and Otto-Ślusarczyk, Dagmara and Madetko-Alster, Natalia and Wiercińska-Drapało, Alicja and Darewicz, Maciej and Struga, Marta and Alster, Piotr},
title = {Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {12122},
doi = {10.3390/ijms262412122}
}
EUVIMED